| Schedule of Earnings Per Share, Basic and Diluted |
The following summarizes the calculation of net income (loss) per share: | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | (Dollars in thousands, except per share amounts) | 2026 | | 2025 | | 2026 | | 2025 | | Numerator | | | | | | | | | Net income (loss) | $ | (8,908) | | | $ | 247 | | | $ | (17,962) | | | $ | 6,359 | | | | | | | | | | | Denominator | | | | | | | | | Denominator for basic net income (loss) per share - weighted average outstanding shares of common stock | 269,602,747 | | | 262,565,500 | | | 268,331,812 | | | 249,106,383 | | | Dilutive effect of common stock options and SARs | — | | | 3,355,271 | | | — | | | 2,899,471 | | | Dilutive effect of RSUs | — | | | 2,959,976 | | | — | | | 2,688,180 | | | Dilutive effect of warrants | — | | | 2,215,180 | | | — | | | 1,836,580 | | | Dilutive effect of ESPP | — | | | 8,093 | | | — | | | 8,451 | | | Denominator for diluted net income (loss) per share - weighted average outstanding shares of common stock and assumed conversions | 269,602,747 | | | 271,104,020 | | | 268,331,812 | | | 256,539,065 | | | Basic net income (loss) per share | $ | (0.03) | | | $ | — | | | $ | (0.07) | | | $ | 0.03 | | | Diluted net income (loss) per share | $ | (0.03) | | | $ | — | | | $ | (0.07) | | | $ | 0.02 | |
|
| Schedule of Anti-Dilutive Securities Excluded from Calculation of Diluted Net Loss per Share |
The shares in the table below were excluded from the calculation of diluted net loss per share, prior to the use of the treasury stock method, due to their anti-dilutive effect: | | | | | | | Three and Six Months Ended June 30, 2026 | | Outstanding common stock options | 21,410,352 | | SARs | 635,313 | | Unvested RSUs | 8,096,781 | | | | Warrants | 2,115,385 | | Total | 32,257,831 |
|